Generated by AI
Sorrento Therapeutics Inc. is a clinical and commercial stage biopharmaceutical company dedicated to developing innovative therapies for unmet medical needs. It focuses on cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases by leveraging proprietary technologies such as the G-MAB antibody library and targeted delivery modalities like CAR-T and DAR-T cell therapies. The company also develops pain management solutions, including resiniferatoxin and SEMDEXA, and has been involved in COVID-19 therapeutic and vaccine development. Sorrento Therapeutics operates across multiple sectors in the healthcare industry, contributing to advancements in biotechnology and pharmaceuticals.
Website4955 Directors Place
San Diego, CA, 92121
United States
Summary of Oct 10's posts. Generated by AI.
Summary of Apr 15's posts. Generated by AI.
Summary of Mar 20's posts. Generated by AI.
Summary of Feb 22's posts. Generated by AI.
Investors talking about SRNE also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.